Verity Asset Management Lowered By $330,834 Its Halliburton Co. (HAL) Stake; Newlink Genetics (NLNK) Has 1.51 Sentiment

March 21, 2018 - By Adrian Mccoy

NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products for the treatment of cancer. The company has market cap of $273.47 million. The Company’s portfolio includes biologic product candidates based on its HyperAcute cellular immunotherapy technology, which is designed to stimulate the human immune system to attack cancer cells; and small-molecule product candidates that are focused on breaking the immune system's tolerance to cancer by inhibiting the indoleamine-2, 3-dioxygenase pathway and the tryptophan-2, 3-dioxygenase pathway. It currently has negative earnings. The firm is developing IDO pathway inhibitors comprising indoximod that is in multiple Phase I and Phase II clinical trials for patients with melanoma, pancreatic cancer, malignant brain tumors, metastatic breast cancer, acute myeloid leukemia, prostate cancer, and non-small cell lung cancer ; and GDC-0919 and atezolizumab (MPDL3280A) that is in Phase Ib clinical trials for patients with locally advanced or metastatic solid tumors.

Verity Asset Management Inc decreased Halliburton Co. (HAL) stake by 51.98% reported in 2017Q3 SEC filing. Verity Asset Management Inc sold 7,877 shares as Halliburton Co. (HAL)’s stock declined 11.04%. The Verity Asset Management Inc holds 7,277 shares with $312,000 value, down from 15,154 last quarter. Halliburton Co. now has $41.19B valuation. The stock increased 3.48% or $1.585 during the last trading session, reaching $47.075. About 3.30M shares traded. Halliburton Company (NYSE:HAL) has risen 19.03% since March 21, 2017 and is uptrending. It has outperformed by 2.33% the S&P500.

Analysts await Halliburton Company (NYSE:HAL) to report earnings on April, 23 before the open. They expect $0.44 earnings per share, up 1,000.00% or $0.40 from last year’s $0.04 per share. HAL’s profit will be $384.96M for 26.75 P/E if the $0.44 EPS becomes a reality. After $0.53 actual earnings per share reported by Halliburton Company for the previous quarter, Wall Street now forecasts -16.98% negative EPS growth.

Verity Asset Management Inc increased Ps Db Usd Idx Bl Fd (UUP) stake by 19,811 shares to 46,891 valued at $1.15M in 2017Q3. It also upped Ishares Floating Rate Bond Etf (FLOT) stake by 24,539 shares and now owns 193,108 shares. Vanguard Intl Equity Index Fds Msci Europe Etf (VGK) was raised too.

Among 42 analysts covering Halliburton Company (NYSE:HAL), 37 have Buy rating, 0 Sell and 5 Hold. Therefore 88% are positive. Halliburton Company had 151 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Monday, August 28 with “Buy”. The firm has “Buy” rating given on Monday, January 22 by Loop Capital Markets. Goldman Sachs maintained Halliburton Company (NYSE:HAL) rating on Thursday, October 20. Goldman Sachs has “Buy” rating and $53 target. The firm earned “Buy” rating on Thursday, July 21 by Deutsche Bank. The firm has “Market Perform” rating given on Wednesday, April 26 by Cowen & Co. The stock of Halliburton Company (NYSE:HAL) has “Buy” rating given on Wednesday, July 22 by Argus Research. The stock of Halliburton Company (NYSE:HAL) earned “Overweight” rating by Barclays Capital on Thursday, October 20. Citigroup maintained Halliburton Company (NYSE:HAL) rating on Monday, May 16. Citigroup has “Buy” rating and $49 target. Piper Jaffray maintained the stock with “Buy” rating in Thursday, December 14 report. The company was maintained on Tuesday, January 23 by Seaport Global.

Investors sentiment increased to 1.15 in 2017 Q3. Its up 0.30, from 0.85 in 2017Q2. It increased, as 84 investors sold HAL shares while 297 reduced holdings. 71 funds opened positions while 254 raised stakes. 679.57 million shares or 0.21% less from 681.00 million shares in 2017Q2 were reported. Us Commercial Bank De stated it has 0.03% of its portfolio in Halliburton Company (NYSE:HAL). Winslow Evans & Crocker holds 0.12% or 7,946 shares. National Bank Hapoalim Bm reported 8,221 shares. Reilly Advisors Ltd Liability Corporation stated it has 28,342 shares or 0.2% of all its holdings. Private Na reported 9,975 shares. Fincl Bank accumulated 3,328 shares. Welch Llc holds 3,220 shares or 0.02% of its portfolio. 170,575 were reported by Waratah Advsr Limited. 15,377 are owned by Ing Groep Nv. Palisade Asset Limited Liability invested 0.23% of its portfolio in Halliburton Company (NYSE:HAL). Etrade Cap Mngmt Limited Liability Corp stated it has 67,933 shares or 0.11% of all its holdings. Laurion Capital Limited Partnership has 0.02% invested in Halliburton Company (NYSE:HAL) for 112,296 shares. State Board Of Administration Of Florida Retirement Systems, a Florida-based fund reported 1.25 million shares. Cap Invest Advisors Llc holds 0.04% in Halliburton Company (NYSE:HAL) or 11,899 shares. Aspen Investment Mngmt invested in 0.17% or 4,836 shares.

Since January 2, 2018, it had 0 insider buys, and 10 selling transactions for $8.39 million activity. Shares for $1.58 million were sold by Carre Eric on Monday, January 22. 39,287 shares were sold by Voyles Robb L., worth $2.16M. 2,937 shares were sold by Beaty Anne L., worth $151,459. On Monday, January 22 Miller Jeffrey Allen sold $1.60 million worth of Halliburton Company (NYSE:HAL) or 29,025 shares. Another trade for 4,583 shares valued at $251,835 was made by McKeon Timothy on Monday, January 22. 12,977 Halliburton Company (NYSE:HAL) shares with value of $713,475 were sold by Brown James S.

Redmile Group Llc holds 0.63% of its portfolio in NewLink Genetics Corporation for 1.25 million shares. Perceptive Advisors Llc owns 450,000 shares or 0.17% of their US portfolio. Moreover, Rhenman & Partners Asset Management Ab has 0.13% invested in the company for 100,000 shares. The New York-based Pdt Partners Llc has invested 0.12% in the stock. Endurant Capital Management Lp, a California-based fund reported 36,100 shares.

The stock increased 4.10% or $0.29 during the last trading session, reaching $7.36. About 331,181 shares traded. NewLink Genetics Corporation (NLNK) has risen 49.90% since March 21, 2017 and is uptrending. It has outperformed by 33.20% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: